Summary
Teva Pharmaceuticals USA, a drug maker in New Jersey, is recalling some blood pressure medications due to high levels of a cancer-causing impurity. This recall affects several types of Prazosin Hydrochloride capsules, which are commonly used to manage high blood pressure. The FDA categorized this recall as Class II, meaning the health risk is relatively low.
Key Facts
- Teva Pharmaceuticals USA is recalling certain blood pressure medications.
- The recall is due to high levels of an impurity called N-nitroso Prazosin impurity C, which can cause cancer.
- The affected medications are Prazosin Hydrochloride capsules in 1 mg, 2 mg, and 5 mg doses.
- Approximately 181,659 bottles of the 1 mg dose, 291,512 bottles of the 2 mg dose, and 107,673 bottles of the 5 mg dose are impacted.
- The FDA classified the recall as Class II, indicating low risk of serious health problems.
- The recalled drugs are used to lower blood pressure and sometimes treat PTSD symptoms.
- Teva has not received any complaints from consumers regarding this issue.
- Patients with these medications are advised to contact their pharmacy and healthcare provider for alternatives.
